Welcome to the European Association for Cancer Research
Europe’s membership association for cancer researchers

7th EACR-OECI Joint Training Course: Molecular Pathology Approach to Cancer

Amsterdam, Netherlands : 8 - 10 May 2017


Molecular pathology is one of the linchpins of precision medicine. No longer can treatment decisions be made solely on the basis of histopathological analyses - because genomic analyses of human cancers are resulting in the identification of the genetic determinants of tumourigenesis, cancer progression and therapy response.

Pathologists’ role in the implementation of molecular tests in diagnostic practice and the ability of pathology laboratories to perform these tests and communicate the results to oncologists are very important to the successful translation of scientific advancements into benefit to patients.

This course aims to provide a comprehensive overview of the state-of-the-art molecular pathology approaches and their application, and to discuss current genomics and molecular pathology of solid malignancies.

Target audience

This course will provide a discussion of current concepts in molecular pathology, molecular pathology methods and their application, which would be beneficial for practicing pathologists and oncologists, residents and fellows in pathology and oncology, and molecular biologists with an interest in molecular pathology and precision medicine.

Topics to be covered

  • The role of the pathologist in precision medicine
  • Massively parallel sequencing methods and data interpretation
  • Perspectives in molecular testing for clinical decision-making in oncology in Europe and USA
  • The molecular pathology of immunotherapy response
  • Molecular pathology of breast cancer and the usefulness of transcriptomic and genomic biomarkers in breast cancer pathology and oncology practice
  • Novel findings in ovarian and endometrial cancers
  • Targeted therapies in melanoma
  • KIT and novel therapeutic targets in gastrointestinal stromal tumours
  • Genomics of lung and colorectal cancers, and the use of genetic biomarkers for therapeutic decision-making
  • Molecular classification of sarcomas and central nervous system tumours
  • Genomics of prostate and kidney cancers

Scientific Programme Committee: Richard Marais (UK), Jorge Reis-Filho (USA), Giorgio Stanta (Italy), Marc van de Vijver (Netherlands)

CME Accreditation

The 7th EACR-OECI Joint Training Course: Molecular Pathology Approach to Cancer has been granted 12 European CME credits (ECMEC) by the European Accreditation Council for Continuing Medical Education (EACCME).

Key dates

Bursary Application Deadline:
28 February 2017

Registration Deadline:
28 April 2017

"This amazing new field of molecular pathology is inspiring not only for pathologists but also for the molecular biologists, chemists, biochemists, clinical geneticists and other scientists. This great course was dedicated to molecular alterations in different type of tumors with the emphasis on establishing new approaches to fight cancer based on new achievements in molecular genetics. All lecturers showed where we currently are in this field, they presented the newest results from many new studies and pointed out in what direction we are going. This was indeed a great course, one of the best in this field!"

Feedback from a participant in the 2016 course

Course Organisers



Sorry. You need to upgrade your browser

You are using Internet Explorer 8

This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.

Thank you.